查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827726

2025年全球药物筛检市场报告

Drug Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物筛检市场规模迅速扩张，从2024年的85.7亿美元成长到2025年的97.2亿美元，复合年增长率达13.3%。在此期间，成长主要源自于药物检测、医疗保健和临床诊断、药物滥用治疗、研发投入以及药物检测套组和设备使用量的增加。

预计未来几年药物筛检市场将快速成长，到2029年将达到168.6亿美元，年复合成长率(CAGR)为14.8%。预测期内的增长可归因于大麻合法化和阿片类药物危机、体育赛事的兴起、照护现场和快速检测、不断变化的药物政策和法规、职场健康和健康计划的扩展以及国际市场的扩张。预测期内的主要趋势包括先进的药物检测技术、远端医疗和远端检测、研发投资、创新药物检测套组和设备以及检测技术的进步。

药物筛检是一种专门为临床试验设计和优化的药物检测方法。它透过分析血液、尿液、头髮和唾液来检测因吸毒而残留在体内的化学物质、污染物和其他非法物质。

药物筛检产品的主要类型包括快速检测设备、耗材和其他相关产品。快速检测设备是一种使用者友好的筛检工具，比传统的实验室检测更快提供结果。药物筛检使用各种样本，包括口腔液、头髮、尿液和呼吸。这些筛检适用于药物检测实验室、职场、刑事司法和执法机构、医院、药物治疗中心、个人使用者、疼痛管理中心、学校和大学。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供药物筛检市场统计数据，例如全球药物筛检行业市场规模、各地区市场份额、各竞争对手的筛检筛检市场、市场趋势和商机，以及您在药物筛检行业取得成功所需的数据。本药物筛检市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为14.8%，较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接影响美国，导致筛检电离源和高通量筛选板的供应链中断，这些产品主要来自加拿大和丹麦等关键地区，这可能会延迟药物开发并增加药物研发成本。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，这种影响也可能更为广泛。

预计药物筛检市场的成长将受到药物和酒精消费量增加的推动。药物成瘾是一种影响大脑和行为的疾病，导致不受控制地使用合法或非法物质，例如酒精、大麻和尼古丁。随着药物和酒精成瘾率的上升，相关的健康风险也在增加，因此需要进行药物筛检。 2022 年，全球对药物和酒精消费的担忧依然强烈，全国药物使用和健康调查 (NSDUH) 报告称，12 岁及以上美国人的药物使用率同比增长 3.8%。此外，该年龄组中 21.4% 的人报告在过去一年中使用过非法药物或滥用处方笺药。持续的疫情进一步加剧了毒品风险，某些地区年轻人的大麻消费量增加了四倍。药物和酒精消费量的增加极大地促进了药物筛检市场的成长。

预计未来药物滥用治疗需求的不断增长将推动药物筛检市场的成长。药物滥用是指使用有害物质，其剂量足以对使用者和他人造成不利影响。药物筛检有助于识别体内通常不存在的化合物。这个过程始于筛检测试，然后进行二次测试以检测和确认特定物质。因此，药物滥用治疗需求的不断增长将支持市场扩张。例如，根据美国卫生与公共服务部2023年8月发布的报告，美国有超过2,700万人报告近期非法使用药物或滥用处方药。此外，近四分之一的成年人和青少年承认在过去一个月内有过酗酒和饮酒行为。据估计，药物滥用每年造成的经济损失（酒精）为2,490亿美元，非法药物为1,930亿美元。因此，在预测期内，药物滥用治疗需求的不断成长将推动药物筛检市场的成长。

药物筛检市场的一个显着趋势是创新产品的推出。该领域的主要企业正在积极开发和推出创新产品，以满足快速成长的行业需求并巩固其市场地位。 COVID-19 疫情改变了药物筛检的方法，刺激了创新和新产品的开发。各公司正努力为实验室创造更有效、更广泛适用的药物检测方法。例如，2022 年 9 月，日本医疗保健公司 Sysmex Corporation 推出了 UF-1500 全自动尿液颗粒分析仪。这款专为尿沉渣检测和筛检设计的创新产品继承了 UF-5000 全自动尿液颗粒分析仪的功能和易用性，同时实现了更紧凑的尺寸。这体现了药物筛检市场创新产品发布的趋势。

药物筛检市场中的公司越来越多地将策略伙伴关係和联盟视为加强财务状况、增强产品系列和扩大地理覆盖范围的手段。策略联盟是两方或多方之间达成的协议，旨在共同追求商定的目标，同时维持组织独立性。例如，2022 年 12 月，英国生物製药公司 PhoreMost Ltd. 和日本生物技术公司 ThinkCyte Inc. 宣布建立策略研究联盟，专注于透过应用人工智慧 (AI) 在表型分析方面的最新进展。该联盟将 PhoreMost 的 SITESEEKER 平台（旨在识别适合未来治疗方法的新标靶）与 ThinkCyte 的 Ghost Cytometry 技术（一种由 AI 驱动的细胞表征和分选平台）相结合。透过结合这些创新技术，该伙伴关係关係旨在提高表型分析的效率和有效性。透过利用人工智慧和机器学习，该联盟有可能识别新的药物标靶并加速有效疗法的开发。

2022年4月，Saladax Biomedical, Inc.（一家专注于开发、生产和销售快速测定治疗药物浓度的美国公司）从比利时製药公司杨森製药（Janssen Pharmaceutica NV）收购了与抗精神病药物检测和筛检相关的专利组合。此次收购使Saladax能够开发与医院常用化学分析仪以及适用于无法进行集中检测的场所的即时诊断设备相容的检测方法。这些检测方法透过为医疗保健专业人员提供快速、可操作的结果，解决了严重精神疾病 (SMI) 患者尚未满足的重大临床需求。此次合作体现了策略性收购如何有助于满足临床需求并扩大药物筛检市场的产品供应。

参与药物筛检市场的主要企业包括 Laboratory Corporation、Quest Diagnostics Incorporated、OraSure Technologies Inc.、Alfa Scientific Designs Inc.、Abbott Laboratories、Thermo Fisher Scientific Inc.、Dragerwerk AG & Co. KGaA、LifeLoc Technologies Inc.、MPD Inc.、Omeics Inc. Roche Ltd.、Shimadzu Corporation、Siemens Healthineers AG、Medtox Scientific Inc.、American Screening Corporation、Clinical Reference Laboratory Inc、Express Diagnostics International Inc.、Global Drug Testing Services、Kroll Laboratory Specialists Inc.、Medscreen Laboratories Global、National Scrlin Services、Kroll Laboratory Specialists Inc.、Medscreen Laboratories、National Scrlin Services、Krolls、MACcani​​stals Eaborscreen Laboratories、N 它Laboratories、Intertek Group plc 和 Eurofins Scientific SE。

2024年药物筛检市场最大的地区是北美。预计亚太地区将成为预测期内药物筛检市场成长最快的地区。药物筛检市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

药物筛检市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

药物筛检市场包括检测套组、试剂和其他耗材的销售。该市场的价值指的是“出厂价”，即商品製造商或创造者出售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接出售给最终客户的价值。该市场中的商品价值还包括商品创造者出售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药物筛检：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球药物筛检市场：成长率分析
  • 全球药物筛检市场表现：规模与成长，2019-2024
  • 全球药物筛检市场预测：规模与成长，2024-2029年，2034年
  • 全球药物筛检：总目标市场（TAM）

第六章 市场细分

  • 全球药物筛检市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 快速检测装置
  • 耗材
  • 其他产品
  • 全球药物筛检市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 口腔液体样本
  • 头髮样本
  • 尿液样本
  • 呼气样本
  • 其他样本类型
  • 全球药物筛检市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 药物检测实验室
  • 职场
  • 刑事司法和执法
  • 医院
  • 戒毒中心
  • 个人用户
  • 疼痛管理中心
  • 学校和大学
  • 全球药物筛检市场：按快速检测设备（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 尿液药物检测套组
  • 唾液药物检测套组
  • 血液药物检测设备
  • 即时测试条
  • 全球药物筛检市场：按耗材（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和测定法
  • 采样装置
  • 校准标准
  • 全球药物筛检市场：依产品类型细分、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 实验设备
  • 软体解决方案
  • 储存和运输解决方案

第七章 区域和国家分析

  • 全球药物筛检市场：区域分析、预测与成长，2019-2024 年、2024-2029 年、2034 年
  • 全球药物筛检市场：依国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 药物筛检市场：竞争格局
  • 药物筛检市场：公司简介
    • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Thermo Fisher Scientific Inc.
  • Dragerwerk AG & Co. KGaA
  • LifeLoc Technologies Inc.
  • MPD Inc.
  • Omega Laboratories Inc.
  • Premier Biotech Inc.
  • Psychemedics Corporation
  • F. Hoffmann-La Roche Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Medtox Scientific Inc.
  • American Screening Corporation
  • Clinical Reference Laboratory Inc.
  • Express Diagnostics International Inc.
  • Global Drug Testing Services

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年药物筛检市场：提供新机会的国家
  • 2029年药物筛检市场：细分领域带来新机会
  • 2029年药物筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21389u

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $8.57 billion in 2024 to $9.72 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to pharmaceutical drug testing, healthcare and clinical diagnostics, substance abuse treatment, research and development investments, and increasing use of drug testing kits and devices.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $16.86 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to legalization of cannabis and opioid crisis, increasing sports events, point-of-care and rapid testing, evolving drug policies and regulations, growing workplace wellness and health programs, and international market expansion. Major trends in the forecast period include advanced drug detection technologies, telemedicine and remote testing, research and development investments, innovative drug testing kits and devices, and technological advancements in testing.

The forecast of 14.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for mass spectrometry ionization sources and high-throughput screening plates, sourced from key regions such as Canada and Denmark, which could lead to slower pharmaceutical development and increased drug discovery expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. In 2022, global concerns about drug and alcohol consumption persisted, with the National Survey on Drug Use and Health (NSDUH) reporting a 3.8% year-over-year increase in drug use among Americans aged 12 and over. The report also highlighted that 21.4% of people in the same age group had used illegal drugs or misused prescription drugs in the past year. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

The increasing demand for substance abuse treatment is expected to drive the growth of the drug screening market in the future. Substance abuse refers to the harmful use of a substance in quantities that negatively affect the user or others. Drug screening helps identify compounds that are typically not present in the body. The process begins with a screening test, which is followed by a secondary test to detect and/or confirm the presence of specific substances, so the growing demand for drug abuse treatment will support market expansion. For example, in August 2023, a report from the U.S. Department of Health and Human Services indicated that over 27 million people in the United States had recently reported using illicit drugs or misusing prescription medications. Furthermore, nearly a quarter of both adults and adolescents admitted to binge drinking in the past month. The annual economic cost of substance misuse is estimated at $249 billion for alcohol and $193 billion for illicit drugs. Therefore, the rising need for substance abuse treatment is propelling the growth of the drug screening market during the forecast period.

A notable trend in the drug screening market is the launch of innovative products. Major companies in this sector are actively developing and introducing innovative products to meet the rapidly growing industry demand and enhance their market positions. The COVID-19 pandemic prompted a shift in drug screening approaches, fostering innovation and new product development. Companies are striving to create more effective and widely applicable drug tests for laboratory use. For example, in September 2022, Sysmex Corporation, a Japan-based healthcare company, launched the UF-1500 Fully Automated Urine Particle Testing Analyzer. This innovative product, designed for urine sediment testing and screening, inherits the functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer while achieving a downsizing of the former model, exemplifying the trend of innovative product launches in the drug screening market.

Companies in the drug screening market are increasingly turning their attention to strategic partnerships and collaborations as a means to enhance their financial strength, fortify their product portfolios, and extend their geographical reach. Strategic collaborations involve agreements between two or more parties to jointly pursue agreed-upon objectives while maintaining their independence as organizations. An illustrative example occurred in December 2022 when PhoreMost Ltd., a UK-based biopharmaceutical company, and ThinkCyte K.K., a Japan-based biotechnology company, announced a strategic research partnership focused on advancing modern phenotypic drug screening through the application of artificial intelligence (AI). This collaboration integrates PhoreMost's SITESEEKER platform, designed to identify optimal new targets for future therapies, with ThinkCyte's Ghost Cytometry technology-a platform leveraging AI for cell characterization and sorting. By combining these innovative technologies, the partnership aims to improve the efficiency and effectiveness of phenotypic drug screening. The collaboration has the potential to identify novel drug targets and facilitate the development of effective therapeutics by leveraging AI and machine learning.

In April 2022, Saladax Biomedical, Inc., a US-based company specializing in the development, manufacturing, and marketing of assays providing rapid therapeutic drug levels, acquired a patent portfolio for antipsychotic drug testing and screening from Janssen Pharmaceutica NV, a Belgium-based pharmaceutical company. This acquisition enabled Saladax to develop tests compatible with chemistry analyzers commonly found in hospitals and a point-of-care instrument suitable for settings where centralized testing is not feasible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by delivering rapid and actionable results to healthcare professionals. The collaboration exemplifies how strategic acquisitions contribute to addressing clinical needs and expanding the offerings in the drug screening market.

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Products: Rapid Testing Devices; Consumables; Other Products
  • 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
  • 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
  • Subsegments:
  • 1) By Rapid Testing Devices: Urine Drug Test Kits; Saliva Drug Test Kits; Blood Drug Test Devices; Instant Test Strips
  • 2) By Consumables: Reagents and Assays; Sample Collection Devices; Calibration Standards
  • 3) By Other Products: Laboratory Equipment; Software Solutions; Storage and Transport Solutions
  • Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; OraSure Technologies Inc.; Alfa Scientific Designs Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Dragerwerk AG & Co. KGaA; LifeLoc Technologies Inc.; MPD Inc.; Omega Laboratories Inc.; Premier Biotech Inc.; Psychemedics Corporation; F. Hoffmann-La Roche Ltd.; Shimadzu Corporation; Siemens Healthineers AG; Medtox Scientific Inc.; American Screening Corporation; Clinical Reference Laboratory Inc.; Express Diagnostics International Inc.; Global Drug Testing Services; Kroll Laboratory Specialists Inc.; Medscreen Laboratories; National Screening Centers Inc.; American Bio Medica Corporation; Mayo Clinic Laboratories; ACM Global Laboratories; Intertek Group plc; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Screening Market Characteristics

3. Drug Screening Market Trends And Strategies

4. Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Screening Market Growth Rate Analysis
  • 5.4. Global Drug Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Screening Total Addressable Market (TAM)

6. Drug Screening Market Segmentation

  • 6.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Testing Devices
  • Consumables
  • Other Products
  • 6.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Fluid Sample
  • Hair Sample
  • Urine Sample
  • Breath Sample
  • Other Sample Types
  • 6.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges
  • 6.4. Global Drug Screening Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Test Kits
  • Saliva Drug Test Kits
  • Blood Drug Test Devices
  • Instant Test Strips
  • 6.5. Global Drug Screening Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents and Assays
  • Sample Collection Devices
  • Calibration Standards
  • 6.6. Global Drug Screening Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Equipment
  • Software Solutions
  • Storage and Transport Solutions

7. Drug Screening Market Regional And Country Analysis

  • 7.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Screening Market

  • 8.1. Asia-Pacific Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Screening Market

  • 9.1. China Drug Screening Market Overview
  • 9.2. China Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Screening Market

  • 10.1. India Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Screening Market

  • 11.1. Japan Drug Screening Market Overview
  • 11.2. Japan Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Screening Market

  • 12.1. Australia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Screening Market

  • 13.1. Indonesia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Screening Market

  • 14.1. South Korea Drug Screening Market Overview
  • 14.2. South Korea Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Screening Market

  • 15.1. Western Europe Drug Screening Market Overview
  • 15.2. Western Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Screening Market

  • 16.1. UK Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Screening Market

  • 17.1. Germany Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Screening Market

  • 18.1. France Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Screening Market

  • 19.1. Italy Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Screening Market

  • 20.1. Spain Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Screening Market

  • 21.1. Eastern Europe Drug Screening Market Overview
  • 21.2. Eastern Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Screening Market

  • 22.1. Russia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Screening Market

  • 23.1. North America Drug Screening Market Overview
  • 23.2. North America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Screening Market

  • 24.1. USA Drug Screening Market Overview
  • 24.2. USA Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Screening Market

  • 25.1. Canada Drug Screening Market Overview
  • 25.2. Canada Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Screening Market

  • 26.1. South America Drug Screening Market Overview
  • 26.2. South America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Screening Market

  • 27.1. Brazil Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Screening Market

  • 28.1. Middle East Drug Screening Market Overview
  • 28.2. Middle East Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Screening Market

  • 29.1. Africa Drug Screening Market Overview
  • 29.2. Africa Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Screening Market Competitive Landscape And Company Profiles

  • 30.1. Drug Screening Market Competitive Landscape
  • 30.2. Drug Screening Market Company Profiles
    • 30.2.1. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Drug Screening Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Dragerwerk AG & Co. KGaA
  • 31.3. LifeLoc Technologies Inc.
  • 31.4. MPD Inc.
  • 31.5. Omega Laboratories Inc.
  • 31.6. Premier Biotech Inc.
  • 31.7. Psychemedics Corporation
  • 31.8. F. Hoffmann-La Roche Ltd.
  • 31.9. Shimadzu Corporation
  • 31.10. Siemens Healthineers AG
  • 31.11. Medtox Scientific Inc.
  • 31.12. American Screening Corporation
  • 31.13. Clinical Reference Laboratory Inc.
  • 31.14. Express Diagnostics International Inc.
  • 31.15. Global Drug Testing Services

32. Global Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Screening Market

34. Recent Developments In The Drug Screening Market

35. Drug Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer